A detailed history of Proficio Capital Partners LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Proficio Capital Partners LLC holds 11,114 shares of AZN stock, worth $855,666. This represents 0.08% of its overall portfolio holdings.

Number of Shares
11,114
Previous 11,114 -0.0%
Holding current value
$855,666
Previous $748,000 0.53%
% of portfolio
0.08%
Previous 0.09%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$61.89 - $69.28 $5,693 - $6,373
-92 Reduced 0.82%
11,114 $748,000
Q3 2023

Oct 18, 2023

SELL
$64.85 - $71.7 $2,853 - $3,154
-44 Reduced 0.39%
11,206 $758,000
Q2 2023

Aug 14, 2023

SELL
$69.91 - $75.81 $7,270 - $7,884
-104 Reduced 0.92%
11,250 $805,000
Q1 2023

Apr 21, 2023

SELL
$63.15 - $71.6 $49.1 Million - $55.6 Million
-776,727 Reduced 98.56%
11,354 $788,000
Q1 2023

Apr 19, 2023

BUY
$63.15 - $71.6 $49.8 Million - $56.4 Million
788,081 New
788,081 $54.7 Million
Q2 2020

Aug 14, 2020

SELL
$43.1 - $55.31 $396,002 - $508,188
-9,188 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$37.79 - $51.33 $347,214 - $471,620
9,188 New
9,188 $410,000
Q3 2019

Nov 13, 2019

SELL
$40.12 - $45.47 $69,929 - $79,254
-1,743 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$37.28 - $41.68 $1,118 - $1,250
30 Added 1.75%
1,743 $72,000
Q1 2019

May 13, 2019

SELL
$35.49 - $43.02 $50,679 - $61,432
-1,428 Reduced 45.46%
1,713 $69,000
Q4 2018

Feb 08, 2019

BUY
$36.86 - $41.49 $6,118 - $6,887
166 Added 5.58%
3,141 $119,000
Q3 2018

Nov 13, 2018

SELL
$34.76 - $39.72 $938 - $1,072
-27 Reduced 0.9%
2,975 $118,000
Q2 2018

Aug 10, 2018

BUY
$34.55 - $37.05 $1,001 - $1,074
29 Added 0.98%
3,002 $105,000
Q1 2018

May 14, 2018

BUY
$32.97 - $36.63 $23,210 - $25,787
704 Added 31.03%
2,973 $104,000
Q4 2017

Feb 09, 2018

BUY
$32.09 - $34.78 $3,497 - $3,791
109 Added 5.05%
2,269 $79,000
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $62,553 - $73,440
2,160
2,160 $73,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $239B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.